D-0627-2018 Class II Terminated

Recalled by Noven Pharmaceuticals, Inc. — Miami, FL

FDA drug recall D-0627-2018 was initiated by Noven Pharmaceuticals, Inc. on Apr 9, 2018 and is designated Class II. Reason for recall: Defective Delivery System: Out of specification for adhesive transfer. The recall status is terminated (terminated Jan 24, 2020). Affected quantity: 9016 boxes of 30 patch each.

Recall Details

Product Type
Drugs
Report Date
Apr 25, 2018
Initiation Date
Apr 9, 2018
Termination Date
Jan 24, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9016 boxes of 30 patch each

Product Description

Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches Rx Only NDC 68968-5552-3 Manufactured for Noven Therapeutics, LLC., Miami, FL 33186 by Noven Pharmaceuticals, Inc. Miami, FL 33186 1-877-567-7857

Reason for Recall

Defective Delivery System: Out of specification for adhesive transfer.

Distribution Pattern

Nationwide.

Code Information

Lot #: 82237 Exp. May 31, 2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0627-2018
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 26, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.